(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide

C107H143F3N24O13S — CID 159510970

IUPAC(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide
SMILESCN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccnn1-c1cccc(C(F)(F)F)c1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1cnn(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1onc(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1cccc(C#N)c1)C1CCCCC1
InChIInChI=1S/C27H35F3N6O3.C27H38N6O3.C27H37N5O4.C26H33N7O3S/c1-17(31-2)24(37)34-23(18-8-4-3-5-9-18)26(39)35-15-7-12-21(35)25(38)33-22-13-14-32-36(22)20-11-6-10-19(16-20)27(28,29)30;1-18(28-2)25(34)31-23(19-11-6-4-7-12-19)27(36)33-16-10-15-22(33)26(35)30-21-17-29-32(3)24(21)20-13-8-5-9-14-20;1-17-22(19-11-6-4-7-12-19)26(36-31-17)30-25(34)21-15-10-16-32(21)27(35)23(20-13-8-5-9-14-20)29-24(33)18(2)28-3;1-16(28-2)23(34)29-22(18-9-4-3-5-10-18)26(36)33-13-7-12-20(33)24(35)30-25-21(31-32-37-25)19-11-6-8-17(14-19)15-27/h6,10-11,13-14,16-18,21,23,31H,3-5,7-9,12,15H2,1-2H3,(H,33,38)(H,34,37);5,8-9,13-14,17-19,22-23,28H,4,6-7,10-12,15-16H2,1-3H3,(H,30,35)(H,31,34);4,6-7,11-12,18,20-21,23,28H,5,8-10,13-16H2,1-3H3,(H,29,33)(H,30,34);6,8,11,14,16,18,20,22,28H,3-5,7,9-10,12-13H2,1-2H3,(H,29,34)(H,30,35)/t17-,21-,23-;18-,22-,23-;18-,21-,23-;16-,20-,22-/m0000/s1
InChIKeyMAPGHRQTUAATSP-JIGIIZRKSA-N
MW2062.54 g/mol
LogP12.11
Rot. Bonds32

About (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide

(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide (PubChem CID 159510970) has the molecular formula C107H143F3N24O13S and a molecular weight of 2062.54 g/mol. Its IUPAC name is (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide
PubChem CID159510970
Molecular FormulaC107H143F3N24O13S
Molecular Weight2062.54 g/mol
Exact Mass2061.09
IUPAC Name(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide
SMILESCN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccnn1-c1cccc(C(F)(F)F)c1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1cnn(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1onc(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1cccc(C#N)c1)C1CCCCC1
InChIInChI=1S/C27H35F3N6O3.C27H38N6O3.C27H37N5O4.C26H33N7O3S/c1-17(31-2)24(37)34-23(18-8-4-3-5-9-18)26(39)35-15-7-12-21(35)25(38)33-22-13-14-32-36(22)20-11-6-10-19(16-20)27(28,29)30;1-18(28-2)25(34)31-23(19-11-6-4-7-12-19)27(36)33-16-10-15-22(33)26(35)30-21-17-29-32(3)24(21)20-13-8-5-9-14-20;1-17-22(19-11-6-4-7-12-19)26(36-31-17)30-25(34)21-15-10-16-32(21)27(35)23(20-13-8-5-9-14-20)29-24(33)18(2)28-3;1-16(28-2)23(34)29-22(18-9-4-3-5-10-18)26(36)33-13-7-12-20(33)24(35)30-25-21(31-32-37-25)19-11-6-8-17(14-19)15-27/h6,10-11,13-14,16-18,21,23,31H,3-5,7-9,12,15H2,1-2H3,(H,33,38)(H,34,37);5,8-9,13-14,17-19,22-23,28H,4,6-7,10-12,15-16H2,1-3H3,(H,30,35)(H,31,34);4,6-7,11-12,18,20-21,23,28H,5,8-10,13-16H2,1-3H3,(H,29,33)(H,30,34);6,8,11,14,16,18,20,22,28H,3-5,7,9-10,12-13H2,1-2H3,(H,29,34)(H,30,35)/t17-,21-,23-;18-,22-,23-;18-,21-,23-;16-,20-,22-/m0000/s1
InChIKeyMAPGHRQTUAATSP-JIGIIZRKSA-N
XLogP12.11
TPSA473.40 Ų
H-Bond Donors12
H-Bond Acceptors26
Rotatable Bonds32
Heavy Atoms148
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002062.54
LogP ≤ 512.11
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1026

Analyze (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide?
The IUPAC name of (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide (CID 159510970) is (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide?
The canonical SMILES for (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide is CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccnn1-c1cccc(C(F)(F)F)c1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1cnn(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1onc(C)c1-c1ccccc1)C1CCCCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1cccc(C#N)c1)C1CCCCC1.
What is the InChIKey of (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide?
The InChIKey is MAPGHRQTUAATSP-JIGIIZRKSA-N. The full InChI is InChI=1S/C27H35F3N6O3.C27H38N6O3.C27H37N5O4.C26H33N7O3S/c1-17(31-2)24(37)34-23(18-8-4-3-5-9-18)26(39)35-15-7-12-21(35)25(38)33-22-13-14-32-36(22)20-11-6-10-19(16-20)27(28,29)30;1-18(28-2)25(34)31-23(19-11-6-4-7-12-19)27(36)33-16-10-15-22(33)26(35)30-21-17-29-32(3)24(21)20-13-8-5-9-14-20;1-17-22(19-11-6-4-7-12-19)26(36-31-17)30-25(34)21-15-10-16-32(21)27(35)23(20-13-8-5-9-14-20)29-24(33)18(2)28-3;1-16(28-2)23(34)29-22(18-9-4-3-5-10-18)26(36)33-13-7-12-20(33)24(35)30-25-21(31-32-37-25)19-11-6-8-17(14-19)15-27/h6,10-11,13-14,16-18,21,23,31H,3-5,7-9,12,15H2,1-2H3,(H,33,38)(H,34,37);5,8-9,13-14,17-19,22-23,28H,4,6-7,10-12,15-16H2,1-3H3,(H,30,35)(H,31,34);4,6-7,11-12,18,20-21,23,28H,5,8-10,13-16H2,1-3H3,(H,29,33)(H,30,34);6,8,11,14,16,18,20,22,28H,3-5,7,9-10,12-13H2,1-2H3,(H,29,34)(H,30,35)/t17-,21-,23-;18-,22-,23-;18-,21-,23-;16-,20-,22-/m0000/s1.
What are the key properties of (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide?
(2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide has a molecular weight of 2062.54 g/mol, XLogP of 12.11, 32 rotatable bonds, 12 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[4-(3-cyanophenyl)thiadiazol-5-yl]-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(3-methyl-4-phenyl-1,2-oxazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(1-methyl-5-phenylpyrazol-4-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-[2-[3-(trifluoromethyl)phenyl]pyrazol-3-yl]pyrrolidine-2-carboxamide is sourced from PubChem (CID 159510970), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).